Kartik Shantilal Patel

Title: Kartik Shantilal Patel: Innovator in Antidepressant Compounds

Introduction

Kartik Shantilal Patel is a notable inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressant compounds. His work is characterized by a focus on creating optically pure compounds that can have a profound impact on mental health treatments.

Latest Patents

Kartik holds a patent for a process for the preparation of an antidepressant compound. The invention provides optically pure (S)-(+)-N-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine, a compound of formula (I). Additionally, it includes the optically pure (S)-isomer of a compound of formula (IV), where R and R both can be methyl, or R is methyl and R is a benzyl or substituted benzyl group. The patent also outlines a process for preparing an acid addition salt of the compound of formula (I).

Career Highlights

Kartik is currently employed at Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise to innovate new pharmaceutical solutions. His dedication to advancing mental health treatments is evident in his patent work.

Collaborations

Kartik has collaborated with notable colleagues such as Rajamannar Thennati and Rajeev Budhdev Rehani. These collaborations have likely contributed to the success of his research and the development of his patented compounds.

Conclusion

Kartik Shantilal Patel is a distinguished inventor whose work in antidepressant compounds showcases his commitment to improving mental health treatments. His innovative approach and successful patent highlight his contributions to the pharmaceutical industry.